|Bid||69.24 x 800|
|Ask||120.00 x 800|
|Day's Range||66.61 - 67.32|
|52 Week Range||53.95 - 80.00|
|Beta (5Y Monthly)||1.05|
|PE Ratio (TTM)||N/A|
|Earnings Date||Oct 26, 2021 - Nov 01, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|Ex-Dividend Date||Dec 10, 2018|
|1y Target Est||82.00|
It is hard to get excited after looking at Taro Pharmaceutical Industries' (NYSE:TARO) recent performance, when its...
Taro (TARO) delivered earnings and revenue surprises of 29.76% and 7.23%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
HAWTHORNE, N.Y., July 27, 2021--TARO PROVIDES RESULTS FOR QUARTER ENDED JUNE 30, 2021